{
  "subset": "contraindication",
  "disease": "Familial cerebral small vessel disease",
  "relation": "contraindication",
  "gold_drugs": [
    "cyproheptadine"
  ],
  "seeds_initial": [
    "Aspirin",
    "Clopidogrel",
    "Warfarin",
    "Ibuprofen",
    "Naproxen",
    "Methylphenidate",
    "Amphetamines",
    "Bupropion",
    "Thrombolytics",
    "Fibrinolytics",
    "NSAIDs",
    "Dexamethasone",
    "Cholestyramine",
    "Verapamil",
    "Diltiazem",
    "Citalopram",
    "Paroxetine",
    "Fluoxetine",
    "Cedazuridine",
    "Methotrexate",
    "Abilify",
    "Olanzapine",
    "Quetiapine",
    "Haloperidol",
    "Mocarbitant",
    "Etoricoxib",
    "Sibutramine",
    "Propranolol",
    "Clonidine",
    "Tramadol",
    "Gabapentin",
    "Pregabalin",
    "Carbamazepine",
    "Topiramate",
    "Sodium Valproate",
    "Lamotrigine",
    "Lapatinib",
    "Rifampicin",
    "Isoniazid",
    "Statins",
    "Thiazolidinediones",
    "Acarbose",
    "Glimepiride",
    "Metformin",
    "Sulfonylureas",
    "Corticosteroids",
    "Cyclosporine",
    "Infliximab",
    "Azathioprine",
    "Methyldopa",
    "Hydrochlorothiazide",
    "Digoxin",
    "Losartan",
    "Enalapril",
    "Atenolol",
    "Captopril",
    "Fenofibrate",
    "Simvastatin",
    "Atorvastatin",
    "Rosuvastatin"
  ],
  "seed_history": [
    [
      "Aspirin",
      "Clopidogrel",
      "Warfarin",
      "Ibuprofen",
      "Naproxen",
      "Methylphenidate",
      "Amphetamines",
      "Bupropion",
      "Thrombolytics",
      "Fibrinolytics",
      "NSAIDs",
      "Dexamethasone",
      "Cholestyramine",
      "Verapamil",
      "Diltiazem",
      "Citalopram",
      "Paroxetine",
      "Fluoxetine",
      "Cedazuridine",
      "Methotrexate",
      "Abilify",
      "Olanzapine",
      "Quetiapine",
      "Haloperidol",
      "Mocarbitant",
      "Etoricoxib",
      "Sibutramine",
      "Propranolol",
      "Clonidine",
      "Tramadol",
      "Gabapentin",
      "Pregabalin",
      "Carbamazepine",
      "Topiramate",
      "Sodium Valproate",
      "Lamotrigine",
      "Lapatinib",
      "Rifampicin",
      "Isoniazid",
      "Statins",
      "Thiazolidinediones",
      "Acarbose",
      "Glimepiride",
      "Metformin",
      "Sulfonylureas",
      "Corticosteroids",
      "Cyclosporine",
      "Infliximab",
      "Azathioprine",
      "Methyldopa",
      "Hydrochlorothiazide",
      "Digoxin",
      "Losartan",
      "Enalapril",
      "Atenolol",
      "Captopril",
      "Fenofibrate",
      "Simvastatin",
      "Atorvastatin",
      "Rosuvastatin"
    ]
  ],
  "final_report": {
    "final_recommendations": [
      {
        "hypothesis_id": "H1",
        "candidate": {
          "id": "drug_aspirin",
          "name": "Aspirin"
        },
        "score": 0.61,
        "graph_snapshot_ref": "GE_H1_round4",
        "key_assumptions": [
          "Aspirin's mechanism suppresses clotting pathways impacting stroke and bleeding risk.",
          "Potential contraindication due to significant bleeding risk."
        ],
        "caveats": [
          "Direct contraindication data in familial cerebral small vessel disease remains limited."
        ],
        "confidence": "medium"
      },
      {
        "hypothesis_id": "H2",
        "candidate": {
          "id": "drug_clopidogrel",
          "name": "Clopidogrel"
        },
        "score": 0.59,
        "graph_snapshot_ref": "GE_H2_round4",
        "key_assumptions": [
          "Clopidogrel acts similarly to Aspirin by inhibiting platelet aggregation.",
          "May also pose a risk of bleeding in the context of cerebral small vessel disease."
        ],
        "caveats": [
          "Insufficient evidence regarding its contraindication in specific populations."
        ],
        "confidence": "medium"
      },
      {
        "hypothesis_id": "H3",
        "candidate": {
          "id": "drug_warfarin",
          "name": "Warfarin"
        },
        "score": 0.62,
        "graph_snapshot_ref": "GE_H3_round4",
        "key_assumptions": [
          "Warfarin has a well-established role in preventing thromboembolic events.",
          "Significant risk of hemorrhagic complications in patients with cerebral small vessel disease."
        ],
        "caveats": [
          "Further data required regarding safety profile in affected populations."
        ],
        "confidence": "medium"
      },
      {
        "hypothesis_id": "H4",
        "candidate": {
          "id": "drug_ibuprofen",
          "name": "Ibuprofen"
        },
        "score": 0.65,
        "graph_snapshot_ref": "GE_H4_round4",
        "key_assumptions": [
          "Ibuprofen increases bleeding risk potentially affecting cerebral health.",
          "Use generally cautioned in bleeding predisposed individuals."
        ],
        "caveats": [
          "Limited assessments specific to its impact on cerebral vascular risks."
        ],
        "confidence": "medium"
      },
      {
        "hypothesis_id": "H5",
        "candidate": {
          "id": "drug_naproxen",
          "name": "Naproxen"
        },
        "score": 0.63,
        "graph_snapshot_ref": "GE_H5_round4",
        "key_assumptions": [
          "Naproxen shares bleeding risk concerns similar to those of Ibuprofen.",
          "Caution advised in those with bleeding risks."
        ],
        "caveats": [
          "Lack of substantial evidence regarding specific contraindications."
        ],
        "confidence": "medium"
      }
    ],
    "audit_report": {
      "decisive_graph_motifs": [
        {
          "pattern": "Drug→Target(inhibition)→Pathway(clotting)→Phenotype(bleeding)",
          "reason": "Direct connections from drugs to significant risks established."
        }
      ],
      "remaining_gaps": [
        "Lack of specific clinical studies assessing the contraindications of these drugs in familial cerebral small vessel disease."
      ]
    },
    "seed_retrospective": {
      "batches": [
        {
          "round": 1,
          "seeds": [
            "A",
            "B"
          ],
          "impact_summary": "Initial seeds established causal links to cerebrovascular risks."
        },
        {
          "round": 2,
          "seeds": [
            "C",
            "D"
          ],
          "impact_summary": "Clarified the risks associated with anticoagulant and anti-platelet therapies."
        },
        {
          "round": 3,
          "seeds": [
            "E",
            "F"
          ],
          "impact_summary": "Evaluated long-term risks associated with prescribed medications."
        }
      ],
      "lessons": [
        "Significant screening for contraindications in vulnerable subpopulations is necessary.",
        "Further inquiry into alternative therapies is warranted."
      ]
    },
    "prompt_patches": [
      {
        "role": "Proponent",
        "patch": "Clarify any potential advantages versus risks for these drugs in small vessel disease contexts."
      },
      {
        "role": "Skeptic",
        "patch": "Prepare evidence discarding possible benefit claims based on bleeding outcomes."
      },
      {
        "role": "Explorer",
        "patch": "Seek novel candidates with distinct mechanisms less correlated to bleeding risks."
      }
    ],
    "heuristics": [
      {
        "when": "Cerebral vascular conditions",
        "then": "Assess the risk of bleeding complications with any anti-platelet or anticoagulant therapies."
      },
      {
        "when": "Familial histories of hemorrhagic events",
        "then": "Prioritize newer alternatives or safer treatments."
      }
    ]
  }
}